scholarly journals TO STUDY THE SAFETY AND EFFICACY OF Nd:YAG HAIR REMOVAL LASER ON PREGNANT AND NON-PREGNANT WOMEN.

2016 ◽  
Vol 4 (10) ◽  
pp. 813-817
Author(s):  
Dr.Sajia Hafeez ◽  
2020 ◽  
Vol 33 (6) ◽  
Author(s):  
Victor Gabriel Clatici ◽  
Cristiana Voicu ◽  
Elena Barinova ◽  
Mihai Lupu ◽  
Alin Laurentiu Tatu

AIDS ◽  
2013 ◽  
Vol 27 (5) ◽  
pp. 739-748 ◽  
Author(s):  
Angela P.H. Colbers ◽  
David A. Hawkins ◽  
Andrea Gingelmaier ◽  
Kabamba Kabeya ◽  
Jürgen K. Rockstroh ◽  
...  

Diabetes Care ◽  
2011 ◽  
Vol 34 (12) ◽  
pp. 2527-2529 ◽  
Author(s):  
H. R. Murphy ◽  
K. Kumareswaran ◽  
D. Elleri ◽  
J. M. Allen ◽  
K. Caldwell ◽  
...  

2021 ◽  
Author(s):  
Yamini Sarwal ◽  
Tanvi Sarwal ◽  
Rakesh Sarwal

Even though evidence for the safety and efficacy of COVID-19 vaccination in pregnancy is emerging, most countries currently do not offer COVID-19 vaccination to pregnant women, while a few leave the decision to the woman. Pregnant women are known to be at high risk of complications from COVID-19. We did a web search on policies for COVID-19 vaccination of pregnant women in two sets of countries – those bearing a high burden of COVID-19 cases globally, and a second set with a high burden of maternal and under five mortality. India and Indonesia fall in both the groups. Of the top 20 COVID-19 affected countries, six countries allow and two have in place guidelines for preferential vaccination of pregnant women. In contrast, none of the high maternal and under-five mortality burden countries have such preferential vaccination guidelines in place. For COVID-19 not to further aggravate already heavy existing burden of maternal and under five mortality, there is a strong case for inclusion of pregnant women as a high priority group for COVID-19 vaccination. We recommend including COVID-19 vaccination in the routine protocol for antenatal care in all countries, particularly India and Indonesia in view of their dual burden.


2003 ◽  
Vol 58 (5) ◽  
pp. 263-274 ◽  
Author(s):  
Lucia Ferro Bricks

Neonates and young children remain susceptible to many serious infectious diseases preventable through vaccination. In general, current vaccines strategies to prevent infectious diseases are unable to induce protective levels of antibodies in the first 6 months of life. Women vaccinated during pregnancy are capable of producing immunoglobulin antibodies that are transported actively to the fetus, and maternal immunization can benefit both the mother and the child. With few exceptions, maternal immunization is not a routine, because of the concerns related to the safety of this intervention. Ethical and cultural issues make the studies on maternal immunization difficult; however, in the last decade, the development of new vaccines, which are very immunogenic and safe has reactivated the discussions on maternal immunization. In this paper we present a review of the literature about maternal immunization based on MEDLINE data (1990 to 2002). The most important conclusions are: 1) there is no evidence of risk to the fetus by immunizing pregnant women with toxoids, polysaccharide, polysaccharide conjugated and inactive viral vaccines; 2) most viral attenuated vaccines are probably safe too, but data is still insufficient to demonstrate their safety; therefore these vaccines should be avoided in pregnant women; 3) in Brazil, there is a need for a maternal immunization program against tetanus. Many new candidate vaccines for maternal immunization are available, but studies should be conducted to evaluate their safety and efficacy, as well as regional priorities based on epidemiological data.


Sign in / Sign up

Export Citation Format

Share Document